Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marvin Chum

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 17, 2020
Christen Shoesmith, Agessandro Abrahao, Tim Benstead, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 11, 2022
Refining items for a preference-based, amyotrophic lateral sclerosis specific, health-related quality of life scaleJill Van Damme, Ayse Kuspinar, Wendy Johnston, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 1, 2025
Differentiating upper- and lower motor neuron diseases using automated acoustic analysisJustin Truong, Leif Simmatis, Timothy Pommée, et al.
Muscle & Nerve|June 6, 2025
Efficacy and Safety of Once Daily Dosing vs. Approved On/Off Dosing of Edaravone Oral Suspension Up to 48 Weeks in Patients With Amyotrophic Lateral Sclerosis (Study MT-1186-A02)Jeffrey Rothstein, Angela Genge, Shari De Silva, et al.
Muscle & Nerve|December 23, 2025
Phase 3b Extension Study MT-1186-A04 to Evaluate the Continued Efficacy and Safety of Edaravone Oral Suspension for Up to an Additional 48 Weeks in Patients With Amyotrophic Lateral SclerosisAngela Genge, Jeffrey Rothstein, Shari De Silva, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 27, 2021
Genetic testing for amyotrophic lateral sclerosis in Canada - an assessment of current practicesKristiana Salmon, Nancy Anoja, Ari Breiner, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 17, 2020
Christen Shoesmith, Agessandro Abrahao, Tim Benstead, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 11, 2022
Refining items for a preference-based, amyotrophic lateral sclerosis specific, health-related quality of life scaleJill Van Damme, Ayse Kuspinar, Wendy Johnston, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 1, 2025
Differentiating upper- and lower motor neuron diseases using automated acoustic analysisJustin Truong, Leif Simmatis, Timothy Pommée, et al.
Muscle & Nerve|June 6, 2025
Efficacy and Safety of Once Daily Dosing vs. Approved On/Off Dosing of Edaravone Oral Suspension Up to 48 Weeks in Patients With Amyotrophic Lateral Sclerosis (Study MT-1186-A02)Jeffrey Rothstein, Angela Genge, Shari De Silva, et al.
Muscle & Nerve|December 23, 2025
Phase 3b Extension Study MT-1186-A04 to Evaluate the Continued Efficacy and Safety of Edaravone Oral Suspension for Up to an Additional 48 Weeks in Patients With Amyotrophic Lateral SclerosisAngela Genge, Jeffrey Rothstein, Shari De Silva, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 27, 2021
Genetic testing for amyotrophic lateral sclerosis in Canada - an assessment of current practicesKristiana Salmon, Nancy Anoja, Ari Breiner, et al.
Pageof 2